10X Genomics, Inc. (TXG)
93.50
+4.74
(+5.34%)
USD |
NASDAQ |
Oct 02, 16:00
94.00
+0.50
(+0.53%)
Pre-Market: 20:00
10X Genomics Price : 93.50 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 90.04 | 94.56 | 88.14 | 93.50 | 3.147M |
| Oct 01, 2026 | 89.30 | 92.92 | 86.75 | 88.76 | 3.251M |
| Sep 30, 2026 | 92.30 | 95.16 | 90.23 | 90.36 | 3.751M |
| Sep 29, 2026 | 89.24 | 91.99 | 87.29 | 90.04 | 3.454M |
| Sep 28, 2026 | 86.00 | 89.95 | 84.27 | 88.50 | 3.371M |
| Sep 25, 2026 | 83.76 | 86.16 | 80.72 | 85.71 | 3.393M |
| Sep 24, 2026 | 75.50 | 85.93 | 74.60 | 84.11 | 4.097M |
| Sep 23, 2026 | 80.37 | 81.93 | 74.75 | 75.62 | 3.477M |
| Sep 22, 2026 | 79.42 | 82.68 | 77.50 | 80.70 | 3.891M |
| Sep 21, 2026 | 79.15 | 80.11 | 76.73 | 79.10 | 2.447M |
| Sep 18, 2026 | 77.64 | 78.08 | 75.21 | 76.60 | 2.887M |
| Sep 17, 2026 | 75.38 | 79.94 | 75.00 | 76.97 | 3.143M |
| Sep 16, 2026 | 74.50 | 77.87 | 71.44 | 72.68 | 4.083M |
| Sep 15, 2026 | 70.13 | 75.61 | 70.11 | 74.39 | 2.905M |
| Sep 14, 2026 | 67.04 | 70.46 | 64.73 | 70.11 | 3.364M |
| Sep 11, 2026 | 67.40 | 69.67 | 67.00 | 68.59 | 1.830M |
| Sep 10, 2026 | 65.17 | 67.70 | 64.02 | 66.38 | 2.436M |
| Sep 09, 2026 | 64.01 | 67.62 | 63.50 | 67.29 | 2.767M |
| Sep 08, 2026 | 61.36 | 66.03 | 61.36 | 65.60 | 3.382M |
| Sep 04, 2026 | 62.54 | 63.48 | 60.99 | 62.65 | 1.470M |
| Sep 03, 2026 | 62.35 | 63.89 | 60.35 | 63.22 | 2.173M |
| Sep 02, 2026 | 60.24 | 63.49 | 59.41 | 61.65 | 1.605M |
| Sep 01, 2026 | 61.79 | 62.33 | 59.76 | 59.98 | 1.964M |
| Aug 31, 2026 | 60.53 | 62.64 | 58.70 | 62.45 | 2.657M |
| Aug 28, 2026 | 63.88 | 65.00 | 60.82 | 61.54 | 2.361M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 188.67 |
| Tempus AI, Inc. | 76.63 |
| Personalis, Inc. | 16.28 |
| Alamar Biosciences, Inc. (California) | 34.36 |
| Beam Therapeutics, Inc. | 24.50 |
Price Related Metrics
| PS Ratio | 19.36 |
| Price to Book Value | 14.76 |
| Price to Free Cash Flow | 98.33 |
| Earnings Yield | -0.63% |
| Market Cap | 12.18B |